The City of Huntsville has taken another step toward bringing pharmaceutical giant Eli Lilly's $6 billion facility to the area.
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
U.S. drug maker Eli Lilly & Co. is slashing the prices of its popular diabetes and weight-loss drugs Mounjaro and Zepbound by ...
Eli Lilly and Company has delivered significant positive developments this week, though its shares experienced a minor pullback in Wednesday's trading sessio ...
It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive ...
Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...
Though it hasn't even wrapped up clinical trials, the weight loss drug retatrutide already has a cult following.
Eli Lilly’s retatrutide exceeds expectations in Phase III, capping off a sparkling 2025 for the obesity titan; an internal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback